Some applications, such as closed-loop automated insulin delivery systems, real-time glucose prediction models, and hypoglycemia detection algorithms, are still under development and have not yet been fully incorporated into routine clinical practice, particularly in the management of type 1 diabetes in pediatric populations [10,24]. This evidence concerns the gene INS and type 1 diabetes mellitus.